Tag Archive for: molluscum contagiosum

The company estimates that about six million people annually in the United States, primarily children, are affected by the condition which previously had no approved treatments.

After making a splash with the full approval of Eisai and Biogen’s Leqembi (lecanemab) on July 6, the FDA has just three scheduled target action dates coming up in the next two weeks; two for cancer and one for a viral skin disease. 

Verrica Pharmaceuticals has received the company’s third Complete Response Letter (CRL) from the U.S. Food and Drug Administration for its New Drug Application for the molluscum contagiosum treatment candidate VP-102.